Blog
ANDA Approvals – Third Quarter 2025
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA….
By: Robins Kaplan LLP
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA….
By: Robins Kaplan LLP